Benzinga

Benzinga

Benzinga

lunedì, agosto 24

Zentalis Pharmaceuticals Inc

ZNTLNASDAQ
Trade with Public
Trade with Public
$3.79
-0.03-0.78%
Ult. Agg.: Aug 24, 3:38 PM
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Zentalis Pharmaceuticals Financials

Zentalis Pharmaceuticals (ZNTL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Zentalis Pharma Q1 EPS $(0.50) Misses $(0.47) Estimate

Zentalis Pharma (NASDAQ:ZNTL) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.47) by 6.38 percent. This is a 25.37 percent increase over losses of $(0.67) per share from
Benzinga Newsdesk

PRO
Zentalis Pharma Q4 EPS $(0.49) Misses $(0.44) Estimate.

Zentalis Pharma (NASDAQ:ZNTL) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.44) by 10.36 percent. This is a 25.76 percent increase over losses of $(0.66) per share from
Benzinga Newsdesk

PRO
Zentalis Pharma Q3 EPS $(0.37) Beats $(0.48) Estimate

Benzinga Newsdesk

PRO
Zentalis Pharma Q2 EPS $(0.37) Beats $(0.51) Estimate, $303.4M Cash, Cash Equivalents And Marketable Securities Supports Operational Runway Into Late 2027

Benzinga Newsdesk

PRO
Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate

Zentalis Pharma (NASDAQ:ZNTL) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.63) by 6.35 percent. This is a 578.57 percent decrease over earnings of $0.14 per share from
Benzinga Newsdesk

PRO
Zentalis Pharmaceuticals FY24 EPS ($2.33) Up From ($4.47) YoY)

Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved